• Profile
Close

Treatment practices for aspirin-exacerbated respiratory disease: Analysis of a national insurance claims database

International Forum of Allergy & Rhinology Nov 15, 2019

Roland LT, Nagy C, Wang H, et al. - Researchers used a large national insurance claims database to assess the current treatment practices for aspirin-exacerbated respiratory disease (AERD) in the United States. Using the MarketScan Database from 2009 to 2015, AERD patients have been identified. In total, 5,628 patients met inclusion criteria for AERD, with mean age 46 years, 60% female; 395 had aspirin desensitization (AsaD) and 2,171 had sinus surgery. The data presented in this work showed a very small portion of AERD patients undergo AsaD. Patients who had AsaD had surgery nearly 2 months prior to AsaD. Compared with patients who did not undergo AsaD, those who had AsaD experienced an increased time between surgeries.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay